Citation Impact
Citing Papers
ORG 10172: a low molecular weight heparinoid anticoagulant with a long half‐life in man.
1987
Parenteral Anticoagulants
2012 Standout
Heparin-Protein Interactions
2002 Standout
Structure and Biological Activity of Heparin
1985
Developmental neurotoxicity of polybrominated diphenyl ether (PBDE) flame retardants
2007
The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mg
1988
Polybrominated Diphenyl Ethers in Leaves and Soil from Typical Electronic Waste Polluted Area in South China
2008
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
E-waste: An assessment of global production and environmental impacts
2009 Standout
An overview of chemical additives present in plastics: Migration, release, fate and environmental impact during their use, disposal and recycling
2017 Standout
Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia
1995
Release of chlorinated, brominated and mixed halogenated dioxin-related compounds to soils from open burning of e-waste in Agbogbloshie (Accra, Ghana)
2015
Overview of toxicological aspects of polybrominated diphenyl ethers: A flame-retardant additive in several consumer products
2008
Antithrombotic Therapy for VTE Disease
2016 Standout
Sonochemical synthesis of nanomaterials
2012 Standout
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Polybrominated diphenyl ethers in road and farmland soils from an e-waste recycling region in Southern China: Concentrations, source profiles, and potential dispersion and deposition
2008
High levels of heavy metals in rice (Oryzasativa L.) from a typical E-waste recycling area in southeast China and its potential risk to human health
2008
Microplastics as contaminants in the marine environment: A review
2011 Standout
Removal of antibiotics in conventional and advanced wastewater treatment: Implications for environmental discharge and wastewater recycling
2007 Standout
Microplastics in bivalves cultured for human consumption
2014 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once- or twice-daily low-molecular-weight heparin
1996
The coagulation cascade: initiation, maintenance, and regulation
1991 Standout
Heparin and Low-Molecular-Weight Heparin
2004
E-waste recycling induced polybrominated diphenyl ethers, polychlorinated biphenyls, polychlorinated dibenzo-p-dioxins and dibenzo-furans pollution in the ambient environment
2007
Polybrominated diphenyl ethers in sewage sludge from Shanghai, China: Possible ecological risk applied to agricultural land
2011
Ice photolysis of 2,2′,4,4′,6-pentabromodiphenyl ether (BDE-100): Laboratory investigations using solid phase microextraction
2012
Organic micropollutants in marine plastics debris from the open ocean and remote and urban beaches
2011
The effect of molecular weight on heparin binding to platelets
1990
Phosphorus flame retardants: Properties, production, environmental occurrence, toxicity and analysis
2012 Standout
Applications of Ultrasound to the Synthesis of Nanostructured Materials
2010 Standout
Pharmacodynamics, Clinical Indications, and Adverse Effects of Heparin
1992
Prevention of Venous Thromboembolism
2004 Standout
Heparin and Low-Molecular-Weight Heparin
1998
How were new medicines discovered?
2011 Standout
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
1995 Standout
Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC) - a multicenter co-operative double-blind trial in comparison with heparin -
1993
Determination of polybrominated diphenyl ethers in soil from e-waste recycling site
2006
Measurement of the affinities of heparins, naturally occurring glycosaminoglycans, and other sulfated polymers for antithrombin III and thrombin
1988
Prevention of Venous Thromboembolism
2008 Standout
Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin
1990
Disseminated Intravascular Coagulation
1999 Standout
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1997 Standout
Platelets, Complement, and Contact Activation: Partners in Inflammation and Thrombosis
2011
Interaction of factor Xa with heparin does not contribute to the inhibition of factor Xa by antithrombin III-heparin
1990
The limitations of applying zero-valent iron technology in contaminants sequestration and the corresponding countermeasures: The development in zero-valent iron technology in the last two decades (1994–2014)
2015 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Current state of sludge production, management, treatment and disposal in China
2015 Standout
Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight Heparins
1990
Cellulose: Fascinating Biopolymer and Sustainable Raw Material
2005 Standout
The physical impacts of microplastics on marine organisms: A review
2013 Standout
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Glycosaminoglycans and the regulation of blood coagulation
1993
A 96-well dot-blot assay for carbohydrate sulfotransferases
2002 StandoutNobel
Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity
1983
Maturation of the hemostatic system during childhood
1992 Standout
The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.
1980
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Serpin Structure, Mechanism, and Function
2002 Standout
Plastic debris in the open ocean
2014 Standout
A new low molecular weight heparin derivative. In vitro and in vivo studies
1983
Energetics and Dynamics of Enzymatic Reactions
2001 StandoutNobel
The relative contributions of antithrombin iii during heparin treatment, and of clinically recognisable risk factors, to early recurrence of venous thromboembolism.
1987
The heparin-enhanced antithrombin III/thrombin reaction is saturable with respect to both thrombin and antithrombin III.
1982
In- and outdoor sources of polybrominated diphenyl ethers and their human inhalation exposure in Guangzhou, China
2007
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Prevention of Venous Thromboembolism
1981
Water Analysis: Emerging Contaminants and Current Issues
2014 Standout
Microplastics in the Marine Environment: A Review of the Methods Used for Identification and Quantification
2012 Standout
Fire retardancy and biodegradability of poly(methyl methacrylate)/montmorillonite nanocomposite
2007
Microplastics and Nanoplastics in Aquatic Environments: Aggregation, Deposition, and Enhanced Contaminant Transport
2017 Standout
Mechanism of inactivation of trypsin by antithrombin
1982
The effect of heparin fragments of different molecular weights on experimental thrombosis and haemostasis
1985
Occurrence and Fate of Pharmaceuticals and Personal Care Products (PPCPs) in Biosolids
2005
Mechanisms of adenosine triphosphate-, thrombin-, and trypsin-induced relaxation of rat thoracic aorta.
1984 StandoutNobel
Low molecular weight heparin
1992
Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association.
1994
Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits
1982
Further characterization of the antithrombin-binding sequence in heparin
1982 Standout
Randomized trial of subcutaneous low-molecular-weight heparin CY 216 (Fraxiparine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism. A dose-ranging study.
1992
Comparison of the Non-Specific Binding of Unfractionated Heparin and Low Molecular Weight Heparin (Enoxaparin) to Plasma Proteins
1993
Hydrodehalogenation with sonochemically prepared Mo2C and W2C
2004
Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4.
1986
Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: A co-operative study
1985
Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma.
1982
Partial NH2- and cooh-terminal sequence analyses of Eco RI DNA restriction and modification enzymes.
1981 StandoutNobel
Brominated Flame Retardants in Children’s Toys: Concentration, Composition, and Children’s Exposure and Risk Assessment
2009
A Randomized Double-Blind Study Between a Low Molecular Weight Heparin Kabi 2165 and Standard Heparin in the Prevention of Deep Vein Thrombosis in General Surgery
1988
Brominated Organic Micropollutants—Igniting the Flame Retardant Issue
2004
Heparin binding properties of human histidine-rich glycoprotein. Mechanism and role in the neutralization of heparin in plasma.
1983
Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosis
1986
A survey of recent advances in selective chemical and enzymic polysaccharide modifications
1985
Characterization of air emissions and residual ash from open burning of electronic wastes during simulated rudimentary recycling operations
2007
Superoxide Ion: Generation and Chemical Implications
2016 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Low-Molecular-Weight Heparins
1997 Standout
Heparin-catalyzed inhibitor/protease reactions: kinetic evidence for a common mechanism of action of heparin.
1983
Plastic and Human Health: A Micro Issue?
2017 Standout
Inhibition of low molecular weight heparin by protamine chloride in vivo
1985
Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa.
1986
Kinetics of factor Xa inhibition by tissue factor pathway inhibitor.
1993
Polymer/layered silicate (clay) nanocomposites: An overview of flame retardancy
2010 Standout
Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin
1989
TiO2-assisted photocatalytic degradation of azo dyes in aqueous solution: kinetic and mechanistic investigations
2004 Standout
Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4
1984
Functions of Cell Surface Heparan Sulfate Proteoglycans
1999 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Life in the “Plastisphere”: Microbial Communities on Plastic Marine Debris
2013 Standout
Mono- and bidimensional 500 MHz 1H-NMR spectra of a synthetic pentasaccharide corresponding to the binding sequence of heparin to antithrombin-III: Evidence for conformational peculiarity of the sulfated iduronate residue
1985
Destruction of Chlorinated Phenols by Dioxygen Activation under Aqueous Room Temperature and Pressure Conditions
2003
The heparin binding site of antithrombin III. Evidence for a critical tryptophan residue.
1980
Low molecular weight heparin
1992
Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously
1983
Photocatalytic transformation of pesticides in aqueous titanium dioxide suspensions using artificial and solar light: intermediates and degradation pathways
2003
Works of G.F. Soderstrom being referenced
Photolytic Debromination of Decabromodiphenyl Ether (BDE 209)
2003
Studies on the blood-anticoagulant activity of sulphated polysaccharides with different uronic acid content
1982
Mechanisms of anticoagulant effects of some sulphated polysaccharides
1982
Studies on the Mechanism of the Rate‐Enhancing Effect of Heparin on the Thrombin‐Antithrombin III Reaction
1979
The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin
1981
Anticoagulant activities and effects on platelets of a heparin fragment with high affinity for antithrombin
1980
Formation of PBCDD and PBCDF during Flue Gas Cooling
2003
PBCDD and PBCDF from Incineration of Waste-Containing Brominated Flame Retardants
2002
The preparation of a heparin analogue frorn alginic acid
1979
Properties of antithrombin III depleted plasma I. Effect of heparin
1980
Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasma
1979